Literature DB >> 29750258

Novel diagnostic tool for prediction of variant spliceogenicity derived from a set of 395 combined in silico/in vitro studies: an international collaborative effort.

Raphaël Leman1,2,3, Pascaline Gaildrat2, Gérald Le Gac4, Chandran Ka4, Yann Fichou4, Marie-Pierre Audrezet4, Virginie Caux-Moncoutier5,6,7, Sandrine M Caputo7, Nadia Boutry-Kryza8, Mélanie Léone8, Sylvie Mazoyer9, Françoise Bonnet-Dorion10, Nicolas Sevenet10, Marine Guillaud-Bataille11, Etienne Rouleau11, Brigitte Bressac-de Paillerets11, Barbara Wappenschmidt12, Maria Rossing13, Danielle Muller14, Violaine Bourdon15, Françoise Revillon16, Michael T Parsons17, Antoine Rousselin1,2, Grégoire Davy1,2, Gaia Castelain2, Laurent Castéra1,2, Joanna Sokolowska18, Florence Coulet19, Capucine Delnatte20, Claude Férec4, Amanda B Spurdle17, Alexandra Martins2, Sophie Krieger1,2,3, Claude Houdayer5,6,7.   

Abstract

Variant interpretation is the key issue in molecular diagnosis. Spliceogenic variants exemplify this issue as each nucleotide variant can be deleterious via disruption or creation of splice site consensus sequences. Consequently, reliable in silico prediction of variant spliceogenicity would be a major improvement. Thanks to an international effort, a set of 395 variants studied at the mRNA level and occurring in 5' and 3' consensus regions (defined as the 11 and 14 bases surrounding the exon/intron junction, respectively) was collected for 11 different genes, including BRCA1, BRCA2, CFTR and RHD, and used to train and validate a new prediction protocol named Splicing Prediction in Consensus Elements (SPiCE). SPiCE combines in silico predictions from SpliceSiteFinder-like and MaxEntScan and uses logistic regression to define optimal decision thresholds. It revealed an unprecedented sensitivity and specificity of 99.5 and 95.2%, respectively, and the impact on splicing was correctly predicted for 98.8% of variants. We therefore propose SPiCE as the new tool for predicting variant spliceogenicity. It could be easily implemented in any diagnostic laboratory as a routine decision making tool to help geneticists to face the deluge of variants in the next-generation sequencing era. SPiCE is accessible at (https://sourceforge.net/projects/spicev2-1/).

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29750258      PMCID: PMC6125621          DOI: 10.1093/nar/gky372

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  35 in total

1.  Evaluation of a 5-tier scheme proposed for classification of sequence variants using bioinformatic and splicing assay data: inter-reviewer variability and promotion of minimum reporting guidelines.

Authors:  Logan C Walker; Phillip J Whiley; Claude Houdayer; Thomas V O Hansen; Ana Vega; Marta Santamarina; Ana Blanco; Laura Fachal; Melissa C Southey; Alan Lafferty; Mara Colombo; Giovanna De Vecchi; Paolo Radice; Amanda B Spurdle
Journal:  Hum Mutat       Date:  2013-08-13       Impact factor: 4.878

2.  Evaluation of in silico splice tools for decision-making in molecular diagnosis.

Authors:  Claude Houdayer; Catherine Dehainault; Christophe Mattler; Dorothée Michaux; Virginie Caux-Moncoutier; Sabine Pagès-Berhouet; Catherine Dubois d'Enghien; Anthony Laugé; Laurent Castera; Marion Gauthier-Villars; Dominique Stoppa-Lyonnet
Journal:  Hum Mutat       Date:  2008-07       Impact factor: 4.878

3.  RNA splice junctions of different classes of eukaryotes: sequence statistics and functional implications in gene expression.

Authors:  M B Shapiro; P Senapathy
Journal:  Nucleic Acids Res       Date:  1987-09-11       Impact factor: 16.971

4.  A high proportion of DNA variants of BRCA1 and BRCA2 is associated with aberrant splicing in breast/ovarian cancer patients.

Authors:  David J Sanz; Alberto Acedo; Mar Infante; Mercedes Durán; Lucía Pérez-Cabornero; Eva Esteban-Cardeñosa; Enrique Lastra; Franco Pagani; Cristina Miner; Eladio A Velasco
Journal:  Clin Cancer Res       Date:  2010-03-09       Impact factor: 12.531

5.  Guidelines for splicing analysis in molecular diagnosis derived from a set of 327 combined in silico/in vitro studies on BRCA1 and BRCA2 variants.

Authors:  Claude Houdayer; Virginie Caux-Moncoutier; Sophie Krieger; Michel Barrois; Françoise Bonnet; Violaine Bourdon; Myriam Bronner; Monique Buisson; Florence Coulet; Pascaline Gaildrat; Cédrick Lefol; Mélanie Léone; Sylvie Mazoyer; Danielle Muller; Audrey Remenieras; Françoise Révillion; Etienne Rouleau; Joanna Sokolowska; Jean-Philippe Vert; Rosette Lidereau; Florent Soubrier; Hagay Sobol; Nicolas Sevenet; Brigitte Bressac-de Paillerets; Agnès Hardouin; Mario Tosi; Olga M Sinilnikova; Dominique Stoppa-Lyonnet
Journal:  Hum Mutat       Date:  2012-05-11       Impact factor: 4.878

6.  SpliceDB: database of canonical and non-canonical mammalian splice sites.

Authors:  M Burset; I A Seledtsov; V V Solovyev
Journal:  Nucleic Acids Res       Date:  2001-01-01       Impact factor: 16.971

7.  ENIGMA--evidence-based network for the interpretation of germline mutant alleles: an international initiative to evaluate risk and clinical significance associated with sequence variation in BRCA1 and BRCA2 genes.

Authors:  Amanda B Spurdle; Sue Healey; Andrew Devereau; Frans B L Hogervorst; Alvaro N A Monteiro; Katherine L Nathanson; Paolo Radice; Dominique Stoppa-Lyonnet; Sean Tavtigian; Barbara Wappenschmidt; Fergus J Couch; David E Goldgar
Journal:  Hum Mutat       Date:  2011-11-03       Impact factor: 4.878

8.  Extensive in silico analysis of NF1 splicing defects uncovers determinants for splicing outcome upon 5' splice-site disruption.

Authors:  K Wimmer; X Roca; H Beiglböck; T Callens; J Etzler; A R Rao; A R Krainer; C Fonatsch; L Messiaen
Journal:  Hum Mutat       Date:  2007-06       Impact factor: 4.878

9.  Splicing and multifactorial analysis of intronic BRCA1 and BRCA2 sequence variants identifies clinically significant splicing aberrations up to 12 nucleotides from the intron/exon boundary.

Authors:  Phillip J Whiley; Lucia Guidugli; Logan C Walker; Sue Healey; Bryony A Thompson; Sunil R Lakhani; Leonard M Da Silva; Sean V Tavtigian; David E Goldgar; Melissa A Brown; Fergus J Couch; Amanda B Spurdle
Journal:  Hum Mutat       Date:  2011-04-12       Impact factor: 4.878

10.  Effects of intronic mutations in the LDLR gene on pre-mRNA splicing: Comparison of wet-lab and bioinformatics analyses.

Authors:  Øystein L Holla; Sigve Nakken; Morten Mattingsdal; Trine Ranheim; Knut Erik Berge; Joep C Defesche; Trond P Leren
Journal:  Mol Genet Metab       Date:  2009-02-10       Impact factor: 4.797

View more
  23 in total

1.  Calibration of Pathogenicity Due to Variant-Induced Leaky Splicing Defects by Using BRCA2 Exon 3 as a Model System.

Authors:  Hélène Tubeuf; Sandrine M Caputo; Teresa Sullivan; Julie Rondeaux; Sophie Krieger; Virginie Caux-Moncoutier; Julie Hauchard; Gaia Castelain; Alice Fiévet; Laëtitia Meulemans; Françoise Révillion; Mélanie Léoné; Nadia Boutry-Kryza; Capucine Delnatte; Marine Guillaud-Bataille; Linda Cleveland; Susan Reid; Eileen Southon; Omar Soukarieh; Aurélie Drouet; Daniela Di Giacomo; Myriam Vezain; Françoise Bonnet-Dorion; Violaine Bourdon; Hélène Larbre; Danièle Muller; Pascal Pujol; Fátima Vaz; Séverine Audebert-Bellanger; Chrystelle Colas; Laurence Venat-Bouvet; Angela R Solano; Dominique Stoppa-Lyonnet; Claude Houdayer; Thierry Frebourg; Pascaline Gaildrat; Shyam K Sharan; Alexandra Martins
Journal:  Cancer Res       Date:  2020-07-08       Impact factor: 12.701

2.  Identification and in-silico characterization of splice-site variants from a large cardiogenetic national registry.

Authors:  Kaveh Rayani; Brianna Davies; Matthew Cheung; Drake Comber; Jason D Roberts; Rafik Tadros; Martin S Green; Jeffrey S Healey; Christopher S Simpson; Shubhayan Sanatani; Christian Steinberg; Ciorsti MacIntyre; Paul Angaran; Henry Duff; Robert Hamilton; Laura Arbour; Richard Leather; Colette Seifer; Anne Fournier; Joseph Atallah; Shane Kimber; Bhavanesh Makanjee; Wael Alqarawi; Julia Cadrin-Tourigny; Jacqueline Joza; Martin Gardner; Mario Talajic; Richard D Bagnall; Andrew D Krahn; Zachary W M Laksman
Journal:  Eur J Hum Genet       Date:  2022-09-22       Impact factor: 5.351

3.  CI-SpliceAI-Improving machine learning predictions of disease causing splicing variants using curated alternative splice sites.

Authors:  Yaron Strauch; Jenny Lord; Mahesan Niranjan; Diana Baralle
Journal:  PLoS One       Date:  2022-06-03       Impact factor: 3.752

4.  AG-exclusion zone revisited: Lessons to learn from 91 intronic NF1 3' splice site mutations outside the canonical AG-dinucleotides.

Authors:  Katharina Wimmer; Esther Schamschula; Annekatrin Wernstedt; Pia Traunfellner; Albert Amberger; Johannes Zschocke; Peter Kroisel; Yunjia Chen; Tom Callens; Ludwine Messiaen
Journal:  Hum Mutat       Date:  2020-03-11       Impact factor: 4.878

5.  High-throughput functional evaluation of BRCA2 variants of unknown significance.

Authors:  Masachika Ikegami; Shinji Kohsaka; Toshihide Ueno; Yukihide Momozawa; Satoshi Inoue; Kenji Tamura; Akihiko Shimomura; Noriko Hosoya; Hiroshi Kobayashi; Sakae Tanaka; Hiroyuki Mano
Journal:  Nat Commun       Date:  2020-05-22       Impact factor: 14.919

6.  Novel PRMT7 mutation in a rare case of dysmorphism and intellectual disability.

Authors:  Jessie Poquérusse; Whitney Whitford; Juliet Taylor; Salam Alburaiky; Russell G Snell; Klaus Lehnert; Jessie C Jacobsen
Journal:  J Hum Genet       Date:  2021-07-09       Impact factor: 3.172

7.  Developmental delay with hypotrophy associated with homozygous functionally relevant REV3L variant.

Authors:  Ewa Sledziewska-Gojska; Rafał Płoski; Agnieszka Halas; Jolanta Fijak-Moskal; Renata Kuberska; Victor Murcia Pienkowski; Aneta Kaniak-Golik; Agnieszka Pollak; Jarosław Poznanski; Malgorzata Rydzanicz; Mirosław Bik-Multanowski
Journal:  J Mol Med (Berl)       Date:  2021-01-20       Impact factor: 4.599

Review 8.  Learning the Regulatory Code of Gene Expression.

Authors:  Jan Zrimec; Filip Buric; Mariia Kokina; Victor Garcia; Aleksej Zelezniak
Journal:  Front Mol Biosci       Date:  2021-06-10

Review 9.  HRness in Breast and Ovarian Cancers.

Authors:  Elizabeth Santana Dos Santos; François Lallemand; Ambre Petitalot; Sandrine M Caputo; Etienne Rouleau
Journal:  Int J Mol Sci       Date:  2020-05-28       Impact factor: 5.923

Review 10.  Is Gene-Size an Issue for the Diagnosis of Skeletal Muscle Disorders?

Authors:  Marco Savarese; Salla Välipakka; Mridul Johari; Peter Hackman; Bjarne Udd
Journal:  J Neuromuscul Dis       Date:  2020
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.